STAT News
NOVEMBER 18, 2022
The document says that public funding for the development of vaccines and treatments should be more transparent, and include provisions to ensure that any resulting products are distributed evenly around the world. The first therapy that delays the onset of type 1 diabetes received approval from the U.S. As of 2019, about 1.9
XTalks
FEBRUARY 8, 2021
They include proteins, monoclonal antibodies and vaccines that are considered to be “ highly similar ” to biological products that have already been approved by the FDA. Like generic forms of synthetic pharmaceuticals, biosimilars have the advantage of being less costly compared to their branded counterparts. What is a Biosimilar?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Delveinsight
AUGUST 25, 2021
The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutical drugs for usage as medications that are administered (or self-administered) to patients in order to cure, vaccinate, or relieve symptoms. Pharmaceutical companies may deal in both generic and brand-name drugs as well as medical devices.
pharmaphorum
JULY 5, 2022
The medicines – which include insulin, oral diabetes agent glibenclamide and cancer chemotherapy oxaliplatin – will be sold under a new Impact brand and are all classed as essential medicines by the World Health Organisation (WHO). ” The post Sanofi makes low-cost medicines pledge for low-income countries appeared first on.
The Pharma Data
MAY 13, 2021
DISCLAIMER: Cory Kelby is a pen name and brand name of letsquitsugar.com. Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms. Ectopic lipid storage and insulin resistance: a harmful relationship. Pathogenesis of Selective Insulin Resistance in Isolated Hepatocytes. Reprod Toxicol. 2014.09.007.
The Pharma Data
MAY 15, 2021
Your ‘Fat Burning Switch’ can’t be activated in the presence of insulin. The ingredients in LumaSlim are the ONLY natural compounds PROVEN to turn your ‘Fat Burning Switch’ ON, even in the presence of insulin! In addition, you’re getting my brand-new, ‘How To Level Up Your Life: The Complete Guide’.
FDA Law Blog
AUGUST 14, 2022
The current Coverage Gap Discount Program will be replaced by a new manufacturer discount program, through which drug manufacturers subsidize 10% of the enrollees’ brand drug costs below the OOP limit and 20% of the costs above that limit.
Expert insights. Personalized for you.
98 
Let's personalize your content